How to buy STERIS shares

Own STERIS shares in just a few minutes.

Picture not described

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

STERIS plc (STE) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$198.98 after a previous close of US$198.37. During the day the price has varied from a low of USD196.72 to a high of USD199.42. The latest price was USD198.22 (25 minute delay). STERIS is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in STERIS

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for STERIS. Find the share by name or ticker symbol: STE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until STERIS reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$195.71, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of STERIS, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of STERIS. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

STERIS share price

Use our graph to track the performance of STE stocks over time.

STERIS shares at a glance

Information last updated 2021-06-15.
OpenUS$198.98
HighUS$199.42
LowUS$196.72
CloseUS$198.22
Previous closeUS$198.37
Change US$-0.15
Change % -0.0756%
Volume 718,840
Information last updated 2021-06-10.
52-week rangeUS$144.8144 - US$216.2935
50-day moving average US$200.9797
200-day moving average US$191.4967
Target priceUS$228.4
PE ratio 42.8704
Dividend yield US$1.57 (0.8%)
Earnings per share (TTM) US$4.63

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro (US, EU stock trading)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy STERIS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

STERIS price performance over time

Historical closes compared with the last close of $198.22

1 week (2021-06-09) 1.37%
1 month (2021-05-14) 0.22%
3 months (2021-03-16) 6.07%
6 months (2020-12-16) 9.06%
1 year (2020-06-16) 27.97%
2 years (2019-06-14) 41.15%
3 years (2018-06-15) 86.88%
5 years (2016-06-16) 197.63%

Is STERIS under- or over-valued?

Valuing STERIS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STERIS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STERIS's P/E ratio

STERIS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, STERIS shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

STERIS's PEG ratio

STERIS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3452. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into STERIS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

STERIS's EBITDA

STERIS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$844.1 million.

The EBITDA is a measure of a STERIS's overall financial performance and is widely used to measure a its profitability.

STERIS financials

Revenue TTM US$3.1 billion
Operating margin TTM 20.11%
Gross profit TTM US$1.4 billion
Return on assets TTM 6.5%
Return on equity TTM 10.86%
Profit margin 12.79%
Book value 45.47
Market capitalisation US$19.8 billion

TTM: trailing 12 months

Shorting STERIS shares

There are currently 3.7 million STERIS shares held short by investors – that's known as STERIS's "short interest". This figure is 14.2% up from 3.2 million last month.

There are a few different ways that this level of interest in shorting STERIS shares can be evaluated.

STERIS's "short interest ratio" (SIR)

STERIS's "short interest ratio" (SIR) is the quantity of STERIS shares currently shorted divided by the average quantity of STERIS shares traded daily (recently around 721499.40944882). STERIS's SIR currently stands at 5.08. In other words for every 100,000 STERIS shares traded daily on the market, roughly 5080 shares are currently held short.

However STERIS's short interest can also be evaluated against the total number of STERIS shares, or, against the total number of tradable STERIS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STERIS's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 STERIS shares in existence, roughly 40 shares are currently held short) or 0.0482% of the tradable shares (for every 100,000 tradable STERIS shares, roughly 48 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against STERIS.

Find out more about how you can short STERIS stock.

STERIS share dividends

26%

Dividend payout ratio: 26.02% of net profits

Recently STERIS has paid out, on average, around 26.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), STERIS shareholders could enjoy a 0.82% return on their shares, in the form of dividend payments. In STERIS's case, that would currently equate to about $1.57 per share.

While STERIS's payout ratio might seem fairly standard, it's worth remembering that STERIS may be investing much of the rest of its net profits in future growth.

STERIS's most recent dividend payout was on 24 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 26 May 2021 (the "ex-dividend date").

Have STERIS's shares ever split?

STERIS's shares were split on a 2:1 basis on 24 August 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your STERIS shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for STERIS shares which in turn could have impacted STERIS's share price.

STERIS share price volatility

Over the last 12 months, STERIS's shares have ranged in value from as little as US$144.8144 up to US$216.2935. A popular way to gauge a stock's volatility is its "beta".

STE.US volatility(beta: 0.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while STERIS's is 0.5533. This would suggest that STERIS's shares are less volatile than average (for this exchange).

STERIS overview

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform